HuGE Literature Finder
Records 1 - 5
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source:
| Antiplatelet and myocardial protective effect of Shexiang Tongxin Dropping Pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial.
Journal of integrative medicine 2022 Jan .
Lin Yan-Jun, Jiao Kun-Li, Liu Bo, Fang Lu, Meng S
| Analysis of the Guiding Role of CYP2C19 Gene Combined With Platelet Function Detection in Antiplatelet Therapy in Patients With Complex Coronary Artery Disease After PCI.
Frontiers in surgery 2022 2 9 839157.
Yu Jiancai, Liu Yongxing, Peng Wanzhong, Liu Juan, Li Ya, Liu Junyan, Jiang Yang, Liu Demin, Xu Zeshe
| PON1 Q192R genotype influences clopidogrel responsiveness by relative platelet inhibition instead of on-treatment platelet reactivity.
Thrombosis research 2013 Aug .
Li X, Zhang L, Chen X, Qu F, Li J, Ma C, Yang J, Xu B, Wang H, Xu Q, Zhang Y, Li Y, Lu C, Yin T
| Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.
BMJ (Clinical research ed.) 2011 343 d4588.
Bauer Tim, Bouman Heleen J, van Werkum Jochem W, Ford Neville F, ten Berg Jurriën M, Taubert Di
| Impact of CYP2C19 polymorphism and smoking on response to clopidogrel in patients with stable coronary artery disease.
Chinese medical journal 2010 Nov 123 (22): 22.
Liu XL, Wang ZJ, Yang Q, Ge HL, Gao F, Liu YY, Shi DM, Zhao YX, Zhou YJ